Urgo Limited

Urgo Limited specializes in advanced wound care solutions, offering a variety of products aimed at improving healing outcomes for patients with different wound types. Founded in 2002, Urgo Limited focuses on developing innovative wound care solutions. The company operates globally, with its headquarters located in the United Kingdom. It has continually adapted its business strategy to meet the evolving needs of healthcare professionals and patients.

Current leadership includes a CEO with a history of involvement in the healthcare sector, enhancing the company’s expertise. Urgo Medical specializes in advanced wound care solutions, designed to address a diverse range of wound types, including leg ulcers, diabetic foot ulcers, pressure ulcers, and surgical wounds. Their core product offerings include the UrgoStart Plus Range, UrgoTul Range, UrgoClean Ag, and UrgoKTwo products, which are tailored to promote healing and improve patient outcomes. These products function by providing optimal moisture, managing exudate, and reducing infection risk, thereby facilitating the natural healing process.

Urgo Medical serves healthcare professionals, patients, and caregivers, primarily across European and North American markets, ensuring that their innovative solutions are accessible to those requiring effective wound management. The company’s commitment to evidence-based practices positions it as a trusted partner for healthcare providers looking to enhance patient care. Urgo Medical generates revenue through direct sales of its wound care products to healthcare professionals, hospitals, and clinics. Transactions typically occur through structured agreements with healthcare systems, facilitating the procurement of their trademarked products such as the UrgoStart Plus and UrgoTul ranges.

The business model primarily operates on a B2B basis, providing tailored solutions that meet the specific needs of healthcare providers. Pricing structures reflect the value of the specialized care and efficacy of their offerings while ensuring affordability and accessibility for end users. This structured approach fosters long-term relationships with clients and supports the continued innovation and development of Urgo Medical's product lines.